Sandhya Kortagere

USPTO Granted Patents = 16 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

Rutgers, the State University of New Jersey

patents

1 out of 504

Albert Einstein College of Medicine

patents

4. 1 out of 4

Palacky University Olomouc

patents

5. 1 out of 11

Mmv Medicines for Malaria Venture

patents

6. 1 out of 2,104

University of Washington

patents

7. 1 out of 269

University of Medicine and Dentistry of New Jersey

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162891 - Glutamate transporter activators and methods using same (2024-12-10),

2. 11744810 - Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder (2023-09-05),

3. 11724998 - PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention (2023-08-15),

4. 11377452 - Glutamate transporter activators and methods using same (2022-07-05),

5. 11345696 - Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same (2022-05-31),

6. 11266612 - D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease (2022-03-08),

7. 10695302 - Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder (2020-06-30),

8. 10543180 - Ddopamine receptor agonists to treat dyskinesia in Parkinson's disease (2020-01-28),

9. 10428059 - Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same (2019-10-01),

10. 10287290 - Compositions useful in treating brain-related diseases or disorders and methods using same (2019-05-14),

11. 9861594 - Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder (2018-01-09),

12. 9675565 - D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease (2017-06-13),

13. 9616065 - Compositions useful in treating brain-related diseases or disorders and methods using same (2017-04-11),

14. 9464057 - Anti-malarial agents (2016-10-11),

15. 9289400 - [object Object] (2016-03-22),

Title: Unveiling the Innovative Mind of Sandhya Kortagere

Introduction:

Sandhya Kortagere is a visionary inventor based in Newtown, PA (US) with a remarkable portfolio of 15 patents to his name. His groundbreaking work in the field of neuroscience and pharmacology has led to the development of novel methods for treating attention disorders, cognitive disorders, dementia associated with neurodegenerative disorders, and gut barrier dysfunction.

Latest Patents:

Sandhya Kortagere's latest patents include:

1. Methods of treating or preventing attention and cognitive disorders: These patents present a method of administering compounds to treat or prevent attention and cognitive disorders in individuals.

2. PXR agonists for gut barrier dysfunction: These patents focus on small molecule agonists of the pregnane X receptor (PXR) for treating or preventing gut barrier dysfunction and related illnesses.

Career Highlights:

Sandhya Kortagere has made significant contributions to the scientific community through his work at respected institutions such as Drexel University and Rutgers, The State University of New Jersey. His dedication to advancing the field of pharmacology and neuroscience has earned him recognition as a pioneering figure in the industry.

Collaborations:

Throughout his career, Sandhya Kortagere has collaborated with esteemed professionals in the field, including Eldo V Kuzhikandahil and Andreia C K Mortensen. Together, they have worked on cutting-edge research projects that have the potential to revolutionize the way we approach healthcare and treatment modalities.

Conclusion:

In conclusion, Sandhya Kortagere stands as a beacon of innovation and ingenuity in the realm of pharmacology and neuroscience. His prolific career, marked by groundbreaking patents and fruitful collaborations, underscores his unwavering commitment to advancing the frontiers of science for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.